Catherine A. Rinaldi

Nedlands, WA, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Journal: Scientific reports
Published: November 03, 2025

The myeloid SRC family kinase HCK regulates breast cancer growth by activating tumor-associated macrophage-led invasion and inhibiting cytotoxic T cell activity.

The myeloid SRC family kinase HCK regulates breast cancer growth by activating tumor-associated macrophage-led invasion and inhibiting cytotoxic T cell activity.

Journal: Frontiers in immunology
Published: September 19, 2025

Novel High Intensity Focused Ultrasound in Debriding Ti Dental Implant-Attached Streptococcus mutans Biofilms.

Novel High Intensity Focused Ultrasound in Debriding Ti Dental Implant-Attached Streptococcus mutans Biofilms.

Journal: International dental journal
Published: July 02, 2025

Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma.

Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma.

Journal: PloS one
Published: September 11, 2022

PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective.

PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective.

Journal: iScience
Published: July 23, 2021

Plasma cell but not CD20-mediated B-cell depletion protects from bleomycin-induced lung fibrosis.

Plasma cell but not CD20-mediated B-cell depletion protects from bleomycin-induced lung fibrosis.

Journal: The European respiratory journal
Published: May 30, 2021

Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.

Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.

Journal: Science translational medicine
Published: January 18, 2017

Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations.

Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations.

Journal: Scientific reports
Published: April 02, 2015

Modulation of innate immune responses by influenza-specific ovine polyclonal antibodies used for prophylaxis.

Modulation of innate immune responses by influenza-specific ovine polyclonal antibodies used for prophylaxis.

Journal: PloS one
Published: November 25, 2013
Showing 1-9 of 9

Last Updated: 09/26/2026